Redo high intensity focused U/S may up urinary symptoms

June 5, 2014
Redo high intensity focused U/S may up urinary symptoms

(HealthDay)—For men with prostate cancer, retreatment with high intensity focused ultrasound is associated with an increase in urinary, but not sexual, side effects, according to a study published in the June issue of The Journal of Urology.

Viktor Berge, M.D., Ph.D., from Oslo University Hospital, and colleagues used United Kingdom registry data on high intensity focused to examine morbidity after primary and redo treatments. Participants included 359 patients who received one whole gland high intensity focused ultrasound treatment for localized , of whom 36.2 percent received retreatment. Patients were followed for a median of 27 months after retreatment. Validated questionnaires were administered before and after ultrasound treatment.

The researchers found that 10.8 and 3.9 percent of patients experienced after the first treatment and retreatment, respectively (P = 0.009). Urethral dilatation was required in 13.8 and 14.0 percent of patients after first and redo ultrasound treatments, respectively (P = 0.7), while bladder neck incision was required in 9.2 and 11.6 percent, respectively (P = 0.2). No leak was reported by 73.3 and 55.1 percent of patients, respectively, before and after retreatment (P < 0.001), and 2.7 and 9.0 percent, respectively, used daily pads (P = 0.07). In analysis of erectile function, no difference was seen in the proportion of who were potent before and after retreatment (56.2 and 56.0 percent, respectively; P = 0.9).

"Redo focused ultrasound is associated with an increase in urinary side effects but sexual side effects do not appear to be significantly increased," the authors write.

Several authors disclosed financial ties to SonaCare Medical.

Explore further: Similar outcomes for robotic, laparoscopic prostatectomy

More information: Abstract
Full Text

Related Stories

Similar outcomes for robotic, laparoscopic prostatectomy

April 17, 2013

(HealthDay)—For men undergoing routine surgical treatment for localized cancer of the prostate, robot-assisted radical prostatectomy (RALP) does not result in better functional outcomes compared to laparoscopic radical ...

Using microbubbles to improve cancer therapy

April 24, 2013

Microbubbles decrease the time and acoustic power of ultrasound required to heat and destroy an embedded target, finds research in BioMed Central's open access journal Journal of Therapeutic Ultrasound. If these results can ...

Testosterone therapy doesn't worsen urinary symptoms

November 25, 2013

(HealthDay)—For hypogonadal men, testosterone replacement therapy is associated with a low risk of worsening lower urinary tract symptoms, according to a study published in the November issue of The Journal of Urology.

Massage enhances fat reduction with cryolipolysis

January 17, 2014

(HealthDay)—Post-treatment manual massage improves the efficacy of cryolipolysis on fat reduction, according to a study published online Dec. 11 in Lasers in Surgery and Medicine.

Focused ultrasound reduces cancer pain

May 5, 2014

When cancer progresses and spreads to the bone, patients often suffer debilitating pain. Now, a new phase III clinical trial shows that non-invasive magnetic resonance guided focused ultrasound treatment that heats the cancer ...

Recommended for you

Zika virus may persist in the vagina days after infection

August 25, 2016

The Zika virus reproduces in the vaginal tissue of pregnant mice several days after infection, according to a study by Yale researchers. From the genitals, the virus spreads and infects the fetal brain, impairing fetal development. ...

In sub-Saharan Africa, cancer can be an infectious disease

August 26, 2016

In 1963, Irish surgeon Denis Parson Burkitt airmailed samples of an unusual jaw tumor found in Ugandan children to his colleague, Anthony Epstein, at Middlesex Hospital in London. Epstein, an expert in chicken viruses and ...

Team discovers how Zika virus causes fetal brain damage

August 24, 2016

Infection by the Zika virus diverts a key protein necessary for neural cell division in the developing human fetus, thereby causing the birth defect microcephaly, a team of Yale scientists reported Aug. 24 in the journal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.